CIK 0001274737
- Non-accelerated filer
- Smaller reporting company
EXAGEN INC.
Sign in to watch- Ticker
- XGN
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 760-560-1501
- Business address
- 1261 LIBERTY WAY, VISTA, CA, 92081
- Former names
- EXAGEN DIAGNOSTICS INC
- 4 Open-market sale Chief Financial Officer sold 1,584 shares at $3.61 ($5,718)
- 4 Open-market sale President and CEO sold 31,787 shares at $11.82 ($375,598)
- 4 Open-market sale Chief Financial Officer sold 20,466 shares at $9.79 ($200,362)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 350,000 shares at $3.30 ($1,155,000)
- 4 Grant or award President and CEO acquired 8,621 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 15,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 112,500 shares (grant or award)
- 4/A Insider Changes in Ownership
- 4 Open-market sale 10% owner sold 200,000 shares at $3.30 ($660,040)
- 4 Open-market buy Chief Financial Officer bought 22,298 shares at $2.98 ($66,448)
- 4 Open-market buy President and CEO bought 24,305 shares at $2.81 ($68,297)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 225,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 2 of 9 · 168 filings